Skip to Content
Return to Navigation

U.S. To Pay Pfizer, BioNTech $1.95 Bln For Millions Of COVID-19 Vaccine Doses-Reuters

The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer Inc (PFE.N) and German biotech firm BioNTech SE’s (22UAy.F) COVID-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday. Reuters, 07/22/2020

Share this article: